• Home
  • About Us
    • Board of Directors
    • Advisory Board
    • Our Team
  • Our Science
    • Ionic Liquid Platform
    • Clinical Pipeline
  • Career
  • More
    • Clinical Trials
    • Press Releases
    • In the News
    • Publications
  • Contact Us
  • More
    • Home
    • About Us
      • Board of Directors
      • Advisory Board
      • Our Team
    • Our Science
      • Ionic Liquid Platform
      • Clinical Pipeline
    • Career
    • More
      • Clinical Trials
      • Press Releases
      • In the News
      • Publications
    • Contact Us
  • Home
  • About Us
    • Board of Directors
    • Advisory Board
    • Our Team
  • Our Science
    • Ionic Liquid Platform
    • Clinical Pipeline
  • Career
  • More
    • Clinical Trials
    • Press Releases
    • In the News
    • Publications
  • Contact Us

Clinical Trials

Developing effective localized treatments to address 

unmet needs across a number of skin conditions

Multicenter, randomized double-blind, vehicle-controlled Phase 2a study for “Atopic Dermatitis”

STUDY IDENTIFIER

NCT05487963

Multicenter, randomized double-blind, vehicle-controlled Phase 2b study for “Atopic Dermatitis”

STUDY IDENTIFIER

NCT06810050

Copyright © 2020 CAGE Bio Inc. - All Rights Reserved.

Powered by

  • Board of Directors
  • Our Team
  • Career
  • Contact Us

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept

Welcome! Latest updates inside.

 CAGE Bio Announces Start of Double-Blind Vehicle-Controlled Clinical Trial of Novel Topical DNA Aptamer Therapy CGB-600 for Vitiligo Treatment


Learn more